每經AI快訊，我(wo)(wo)武生物晚間公(gong)(gong)(gong)告，控股(gu)股(gu)東我(wo)(wo)武咨詢計劃(hua)以大宗(zong)交易(yi)方(fang)式(shi)減(jian)(jian)持公(gong)(gong)(gong)司(si)(si)股(gu)份不(bu)超(chao)過450萬(wan)股(gu)（含本(ben)數(shu)），即(ji)不(bu)超(chao)過公(gong)(gong)(gong)司(si)(si)總(zong)股(gu)本(ben)比例(li)0.86%。我(wo)(wo)武咨詢本(ben)次減(jian)(jian)持的受讓方(fang)為(wei)公(gong)(gong)(gong)司(si)(si)實際控制人之(zhi)一的胡賡熙。公(gong)(gong)(gong)司(si)(si)董事、副總(zong)經理(li)張露計劃(hua)以集中(zhong)競價交易(yi)方(fang)式(shi)減(jian)(jian)持公(gong)(gong)(gong)司(si)(si)股(gu)份不(bu)超(chao)過30萬(wan)股(gu)（含本(ben)數(shu)），擬減(jian)(jian)持數(shu)量(liang)占公(gong)(gong)(gong)司(si)(si)總(zong)股(gu)本(ben)比例(li)不(bu)超(chao)過0.06%。